Africa (WHO region) vs Hong Kong: HIV-positive TB patients on ART (antiretroviral therapy)
Africa (WHO region)
96.0%
in 2024
Hong Kong
100.0%
in 2024
Africa (WHO region) rank
2nd
Hong Kong rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Africa (WHO region)
- Hong Kong
How they compare
Hong Kong currently reports 100.0% against 96.0% in Africa (WHO region), a difference of 4.0%.
The two have swapped places 2 times across 18 shared years of data; in 2003 it was Hong Kong ahead.
Africa (WHO region) ranks 2nd and Hong Kong ranks 1st of 11 groups.
Across the 3 decades both report, Africa (WHO region) averaged higher in 2 and Hong Kong in 1.
Head to head by decade
| Decade | Africa (WHO region) | Hong Kong | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.9% | 53.4% | 22.6% | Hong Kong |
| 2010s | 81.2% | 31.1% | 50.1% | Africa (WHO region) |
| 2020s | 93.2% | 92.2% | 1.0% | Africa (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Africa (WHO region) or Hong Kong?
- Hong Kong, at 100.0% against 96.0% in Africa (WHO region) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Africa (WHO region) and Hong Kong?
- 4.0%, with Hong Kong ahead.
- How many years of comparable data are there for Africa (WHO region) and Hong Kong?
- 18 years are reported by both, from 2003 to 2024.
- How do Africa (WHO region) and Hong Kong rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Africa (WHO region) ranks 2nd and Hong Kong ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.